Kringle Pharma News

Kringle Pharma: Analyst Report Released by Shared Research Inc.

Aug 27 16:00

Kringle Pharma: Announcement of the update of the financial report for the third quarter of the fiscal year ending September 2024

Aug 23 15:50

Kringle Pharma: [Delay] Financial results for the 9 months until June 30, 2024 [Japan standard] (non-consolidated)

Aug 22 14:00

Kringle Pharma: Announcements of individual stocks: Notice of Logmi Finance's article publication on the explanatory video of "Revision of the financial results and financial estimates for the third quarter of September 2024."

Aug 15 12:00

Kringle Pharma: Announcements of individual stocks: Explanation video about the revision of the Q3 financial statements and financial estimates for September 2024 has been posted.

Aug 9 15:20

Kringle Pharma: Announcements of individual stocks regarding the decrease in the amount of capital and capital reserve and the disposal of surplus funds.

Jul 17 15:30

Kringle Pharma: Analyst report released by Shared Research Co., Ltd.

Jun 20 15:45

Kringle Pharma: Announcements of individual stocks: Joint research with Kanazawa University has begun on the application research of HGF (hepatocyte growth factor) for idiopathic pulmonary fibrosis.

Jun 18 14:00

Kringle Pharma: Announcements of individual stocks: Update of the financial report for the second quarter of the September 2024 period.

Jun 13 15:30

Kringle Pharma: Announcements of individual stocks regarding the establishment of a record date for the convening of an extraordinary general meeting of shareholders.

Jun 12 15:45

Kringle Pharma: Presentation at the 2nd Spinal Cord Injury Investor Symposium.

Jun 11 14:50

Kringle Pharma: Announcements of individual stocks: Speech at the 2nd Annual Spinal Cord Injury Investor Symposium in the USA.

Jun 11 14:50

KRINGLE PHARMA: Notice Concerning Mass Exercise of Stock Acquisition Rights with Exercise Price Amendment Clause

May 27 14:00

KRINGLE PHARMA: [Delayed] Financial results for the six months ended 2024/3/31 [Japanese GAAP] (unconsolidated)

May 23 10:30

KRINGLE PHARMA: Notice of publication of a transcript of the financial results briefing for the 2nd quarter of the fiscal year ending 2024/9 Logme Finance

May 22 10:30

KRINGLE PHARMA: Notice of determination of generic names for HGF pharmaceuticals in Japan

May 21 14:00

KRINGLE PHARMA: Notice of video posting of financial results briefing for the 2nd quarter of the fiscal year ending September 2024

May 17 17:15

KRINGLE PHARMA: Addition of clinical trial implementation facilities (Sanno Medical Center) to phase III clinical trials of HGF (hepatocyte growth factor) for vocal cord scars

May 16 14:10

KRINGLE PHARMA: A review article on the development of HGF therapeutics for central nervous system diseases such as ALS was published in the journal “Pharmacia”

May 1 15:30

KRINGLE PHARMA: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clause

May 1 10:30